| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 65386 |
DSPE-PEG2000-NH2,474922-26-4,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-氨基,DSPE-PEG-NH2 |
251 |
axc |
2025-02-10 |
| 65387 |
AlKyne-PEG1000-Mal 马来酰亚胺-聚乙二醇-炔基 |
128 |
zyl |
2025-02-10 |
| 65388 |
DSPE-PEG2000-Mal,474922-22-0,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-马来酰亚胺,DSPE-PEG-Mal |
212 |
axc |
2025-02-10 |
| 65389 |
DSPE-PEG2000-IA,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-IA,DSPE-PEG-IA |
123 |
axc |
2025-02-10 |
| 65390 |
cRGD(c[RGDfc])-PEG-DSPE 肿瘤新生血管靶向环肽-聚乙二醇-磷脂 |
169 |
kx |
2025-02-10 |
| 65391 |
DSPE-PEG2000-Folate,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-叶酸,DSPE-PEG-Folate |
217 |
axc |
2025-02-10 |
| 65392 |
DSPE-PEG2000-FITC,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-异硫氰基荧光素,DSPE-PEG-FITC |
165 |
axc |
2025-02-10 |
| 65393 |
DSPE-PEG2000-DBCO,2052955-83-4,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-二苯基环辛炔,DSPE-PEG-DBCO |
202 |
axc |
2025-02-10 |
| 65394 |
cRGD-PEG-Hyd-DSPE 肿瘤靶向肽cRGD-聚乙二醇-腙键-磷脂 |
113 |
kx |
2025-02-10 |
| 65395 |
DBCO-PEG1000-Mal 二苯基环辛炔-聚乙二醇-马来酰亚胺 |
110 |
zyl |
2025-02-10 |
| 65396 |
DSPE-PEG2000-Cy5,DSPE-PEG-Cy5,Cy5标记磷脂 |
175 |
axc |
2025-02-10 |
| 65397 |
IA-PEG1000-FITC 碘代乙酰基-聚乙二醇-荧光素 |
114 |
zyl |
2025-02-10 |
| 65398 |
DSPE-PEG2000-Cy3,,DSPE-PEG-Cy3,荧光标记磷脂 |
119 |
axc |
2025-02-10 |
| 65399 |
RGD-PEG-DSPE RGD肽-聚乙二醇-磷脂 |
129 |
kx |
2025-02-10 |
| 65400 |
IA-PEG1000-IA 碘代乙酰基-聚乙二醇-碘代乙酰基 |
142 |
zyl |
2025-02-10 |
| 65401 |
DSPE-PEG2000-COOH,1403744-37-5,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-羧酸,DSPE-PEG-COOH |
174 |
axc |
2025-02-10 |
| 65402 |
DSPE-PEG2000-CH2COOH,2665069-75-8,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-二氯甲烷羧基,DSPE-PEG-CH2COOH |
145 |
axc |
2025-02-10 |
| 65403 |
Peptides PEG DSPE 多肽-聚乙二醇-二硬脂酰基磷脂酰乙醇胺 |
308 |
kx |
2025-02-10 |
| 65404 |
DSPE-PEG2000-Boronate,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-硼酸酯,DSPE-PEG-Boronate |
294 |
axc |
2025-02-10 |
| 65405 |
Xpeptide-PEG-PCL Xpeptide多肽-聚乙二醇-聚已内酯 |
154 |
kx |
2025-02-10 |
| 65406 |
DSPE-PEG2000-Biotin,740794-01-8,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-生物素,DSPE-PEG-Biotin |
198 |
axc |
2025-02-10 |
| 65407 |
DSPE-PEG5-azide,2112737-73-0,二硬脂酰基磷脂酰乙醇胺-五聚乙二醇-叠氮,DSPE-PEG-azide |
125 |
axc |
2025-02-10 |
| 65408 |
FITC/CY3/CY5/CY7荧光标记方法步骤 |
325 |
WYQ |
2025-02-10 |
| 65409 |
M2pep-PEG-PCL M2型巨噬细胞靶向肽-聚乙二醇-聚已内酯 |
143 |
kx |
2025-02-10 |
| 65410 |
Br-PEG1000-Br 溴-聚乙二醇-溴 |
230 |
zyl |
2025-02-10 |
| 65411 |
选择合适的荧光染料和特异性荧光显微镜 |
282 |
WYQ |
2025-02-10 |
| 65412 |
DSPE-PEG2000-azide,1938081-39-0,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-叠氮,DSPE-PEG-azide |
166 |
axc |
2025-02-10 |
| 65413 |
荧光FITC标记多糖的方法步骤 |
340 |
WYQ |
2025-02-10 |
| 65414 |
DSPE-PEG2000-Amine,474922-26-4,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-氨基,DSPE-PEG-Amine |
154 |
axc |
2025-02-10 |
| 65415 |
T7-PEG-PCL 脑靶向肽T7-聚乙二醇-聚已内酯 |
229 |
kx |
2025-02-10 |
| 65416 |
DSPE-PEG2000-Ald,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-醛基,DSPE-PEG-Ald |
201 |
axc |
2025-02-10 |
| 65417 |
COCl-PEG1000-COCl 琥珀酰氯-聚乙二醇-琥珀酰氯 |
245 |
zyl |
2025-02-10 |
| 65418 |
DSPE-PEG2000-acid,2112738-58-4,二硬脂酰基磷脂酰乙醇胺-四聚乙二醇-羧酸,DSPE-PEG4-acid |
140 |
axc |
2025-02-10 |
| 65419 |
提取和纯化灰树花多糖的方法 |
144 |
WYQ |
2025-02-10 |
| 65420 |
DSPE-PEG2000-acid,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-羧酸,DSPE-PEG-acid |
126 |
axc |
2025-02-10 |
| 65421 |
Cl-PEG1000-Cl 氯化物-聚乙二醇-氯化物 |
149 |
zyl |
2025-02-10 |
| 65422 |
Peptides PEG PCL 多肽-聚乙二醇-聚已内酯 |
144 |
kx |
2025-02-10 |
| 65423 |
Peptides-PEG-PCL 多肽-聚乙二醇-聚已内酯 |
130 |
kx |
2025-02-10 |
| 65424 |
IA-PEG1000-SC 碘代乙酰基-聚乙二醇-琥珀酰亚胺碳酸酯 |
146 |
zyl |
2025-02-10 |
| 65425 |
IA-PEG1000-Mal 碘代乙酰基-聚乙二醇-马来酰亚胺 |
152 |
zyl |
2025-02-10 |
| 65426 |
FITC标记PGF灰树花多糖时调节温度的原因 |
121 |
WYQ |
2025-02-10 |
| 65427 |
Peptides PEG PLA 多肽-聚乙二醇-聚乳酸 |
106 |
kx |
2025-02-10 |
| 65428 |
IA-PEG1000-Biotin 碘代乙酰基-聚乙二醇-生物素 |
127 |
zyl |
2025-02-10 |
| 65429 |
PTP-PEG-N3 胰腺癌靶向肽PTP-聚乙二醇-叠氮 |
135 |
kx |
2025-02-10 |
| 65430 |
PTP-PEG-COOH 胰腺癌靶向肽PTP-聚乙二醇-羧酸 |
112 |
kx |
2025-02-10 |